Antiverse Alternatives & Competitors
12 companies similar to Antiverse — Designing functional antibodies for the most challenging targets.
Companies similar to Antiverse
MSM Protein Technologies, Inc.
Pioneering novel methods for precise targeting of challenging therapeutic proteins in drug...
Light Chain Bioscience | Novimmune SA
Light Chain Bioscience – A brand of Novimmune SA
Plan-les-ouates, Switzerl...
FogPharma
Until everything is druggable.
Cambridge, United States
Rival Readout
Competing with Antiverse? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Absci
Unlocking differentiated biology with generative AI
Vancouver, United States
LabGenius Therapeutics
Combining human and machine intelligence to discover the next generation of therapeutic an...
London, United Kingdom
Relay Therapeutics
Integrating leading-edge computational and experimental science to transform human health....
Cambridge, United States
Anavo Therapeutics BV
UNLOCKING THE PHOSPHATASE TARGET CLASS
Leiden, The Netherlands
Octant
Developing synthetic technology and applying next-generation DNA sequencing, gene synthesi...
Emeryville, United States
Diffuse Bio
We build generative AI for protein therapeutics.
Generate:Biomedicines
Pioneering generative biology to create breakthrough therapeutics.
Somerville, United States
Regor Therapeutics Group
We aspire to be a world class innovative drug discovery company from China.
Shanghai, China
About Antiverse
Antiverse, founded in 2017, is a promising Welsh techbio company that specializes in the design of antibodies targeting difficult drug targets such as GPCRs and ion channels. The company’s mission is encapsulated in its slogan: "Designing functional antibodies for the most challenging targets." With headquarters in Car...
Antibody design for challenging targets, Pharmaceutical partnerships, In silico drug discovery, Machine learning model development
Pharmaceutical companies, Biotech firms, Healthcare researchers
Antibody Design, Challenging Drug Targets, GPCR Therapeutics, Ion Channel Therapeutics, TechBio, Cell Line Engineering, De Novo Antibody Therapeutics, Drug Discovery, Structural Biology, Biotechnology Innovation, Therapeutic Antibodies, Accelerated Drug Development, Advanced Therapeutics
B2B, Platform, SaaS
Licensing, Performance Based, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Antiverse: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Antiverse on 15 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
